Patient Pathfinder: Clinical Trials
Clinical Trials for Myeloproliferative Neoplasms
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myeloproliferative Neoplasms (MPNs), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 116 active Myeloproliferative Neoplasms trials
Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs
Study Type: Interventional Phase 3
P1101 in Treating Patients With Myelofibrosis
Study Type: Interventional Phase 2
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
Study Type: Interventional Phase 3
Ruxolitinib in Thrombocythemia and Polycythemia Vera
Study Type: Interventional Phase 2
Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis
Study Type: Interventional Phase 1
Project: Every Child for Younger Patients With Cancer
Study Type: Observational
Study of DISC-0974 in Participants With Myelofibrosis and Anemia
Study Type: Interventional Phase 1
There are 116 active Myeloproliferative Neoplasms trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now